VTAK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VTAK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Catheter Precision's quarterly buildings and improvements declined from Mar. 2024 ($0.17 Mil) to Jun. 2024 ($0.15 Mil) and declined from Jun. 2024 ($0.15 Mil) to Sep. 2024 ($0.13 Mil).
Catheter Precision's annual buildings and improvements declined from Dec. 2021 ($2.11 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.18 Mil).
The historical data trend for Catheter Precision's Buildings And Improvements can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catheter Precision Annual Data | |||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Buildings And Improvements | Get a 7-Day Free Trial | 2.84 | 2.48 | 2.11 | - | 0.18 |
Catheter Precision Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Buildings And Improvements | Get a 7-Day Free Trial | 0.20 | 0.18 | 0.17 | 0.15 | 0.13 |
Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.
Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.
David A Jenkins | director, officer: Executive Chairman of Board | P.O. BOX 682838, PARK CITY UT 84068 |
Steven K Passey | officer: Chief Financial Officer | 3216 SOUTH HIGHLAND DRIVE, SUITE 200, SALT LAKE CITY UT 84117 |
James Joseph Caruso | director | 28 FIRST AVE, SEASIDE PARK NJ 08752 |
Brian Conn | officer: Chief Financial Officer | MICROISLET, INC., 6370 NANCY RIDGE DRIVE, SUITE 112, SAN DIEGO CA 92121 |
Andrew C. Jackson | officer: CFO & Secretary | 11988 EL CAMINO REAL STE. 650, SAN DIEGO CA 92130 |
Jonathan Will Mcguire | director, officer: Chief Executive Officer | 96 TALAMINE COURT, COLORADO SPRINGS CO 80907 |
Susanne Meline | director | P.O. BOX 515381, #86506, LOS ANGELES CA 90051 |
Martin J Colombatto | director | |
Richard Jr Mejia | director | 2200 FARADAY AVENUE, SUITE 100, CARLSBAD CA 92008 |
William R Enquist | director | 11810 WILLS ROAD, ALPHARETTA GA 30009 |
Joan Stafslien | director | CAREFUSION CORPORATION, 3750 TORREY VIEW COURT, SAN DIEGO CA 92130 |
Daniel Horwood | officer: General Counsel | C/O RA MEDICAL SYTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011 |
Jeffrey J Kraws | officer: Co-President | 3985 RESEARCH PARK DRIVE, ANN ARBOR MI 48108 |
Dean Irwin | director, 10 percent owner, officer: See Remarks | C/O RA MEDICAL SYSTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011 |
Martin Burstein | 10 percent owner | C/O RA MEDICAL SYSTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011 |
From GuruFocus
By ACCESSWIRE • 06-20-2024
By ACCESSWIRE • 05-07-2024
By ACCESSWIRE • 07-01-2024
By ACCESSWIRE • 08-30-2024
By ACCESSWIRE • 08-14-2024
By ACCESSWIRE • 05-13-2024
By ACCESSWIRE • 09-11-2024
By ACCESSWIRE • 09-04-2024
By ACCESSWIRE • 10-25-2024
By ACCESSWIRE • 07-25-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.